Question 1

Which countries lead Hematopoietic Stem Cell Transplantation research?

Accepted Answer

By volume, the United States and China publish the most (1.7k and 923 works in 2022-now).

Question 2

Which institutions lead Hematopoietic Stem Cell Transplantation research?

Accepted Answer

By volume in 2022-now, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Hematopoietic Stem Cell Transplantation research, followed by Harvard University and Peking University.

Question 3

Who are the leading researchers in Hematopoietic Stem Cell Transplantation?

Accepted Answer

The most-cited researchers publishing on Hematopoietic Stem Cell Transplantation include Guido Kroemer, Gad A. Getz and Elaine R. Mardis.

Question 4

Where is Hematopoietic Stem Cell Transplantation research done?

Accepted Answer

The largest centres of Hematopoietic Stem Cell Transplantation research in 2022-now are Beijing (China), Paris (France), Tokyo (Japan) and Houston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Duarte, Lancaster and Memphis.

Question 5

Where is the best place to study Hematopoietic Stem Cell Transplantation?

Accepted Answer

Among universities, judged by research, Harvard University, Peking University and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Question 6

Is Hematopoietic Stem Cell Transplantation research growing?

Accepted Answer

Output in 2022-2025 was 3% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Hematopoietic Stem Cell Transplantation.

Question 7

What are the most cited papers in Hematopoietic Stem Cell Transplantation?

Accepted Answer

The most cited paper in Hematopoietic Stem Cell Transplantation is "Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell" (Dominique A. Bonnet, John Edgar Dick, 1997), with 7,031 citations. Next come "National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report" (5,493) and "A cell initiating human acute myeloid leukaemia after transplantation into SCID mice" (4,789).